Skip to main content

Advertisement

SpringerLink
Log in

A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren’s syndrome-related interstitial lung disease in a Chinese population

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

To characterize the distinctive chest high-resolution computerized tomography (HRCT) features and clinical manifestations of primary Sjögren syndrome (pSS)-related interstitial lung disease (ILD). The demographic data, clinical manifestations, and laboratory and radiological findings of 527 pSS patients were retrospectively analyzed. ILD was defined based on the presences of pulmonary signs in HRCT. Two hundred six of 527 patients were diagnosed as pSS-ILD, and the prevalence was 39.1%. The three most frequent abnormalities in HRCT were reticular pattern (92.7%), ground-glass attenuation (87.4%), and bronchovascular bundle thickening (82%). One hundred twenty-four cases (60.2%) of the pSS-ILD patients had only a single HRCT pattern, which involved 86 non-specific interstitial pneumonitis (NSIP) cases (41.7%), 22 usual interstitial pneumonia (UIP) cases (10.68%), 8 organizing pneumonia (OP) cases (3.9%), and 8 lymphocytic interstitial pneumonia (LIP) cases (3.9%), respectively. Besides, the more important observation was that 82 cases had no less than two HRCT patterns, and NSIP admixed with OP (43.9%), NSIP admixed with UIP (35.4%), and NSIP admixed with LIP (19.5%) were the most frequent. HRCT of pSS-ILD patients demonstrated bilateral infiltrates (99%), with abnormalities predominantly in the lower lobes (89.3%) and subpleural areas (81.1%), and a few lesions were characterized by hilum distributed (8.7%). Pulmonary function tests (PFTs) revealed impaired diffusion capacity for carbon monoxide and total lung capacity, and the rate of small airway lesions in the pSS-ILD patients was 3.5 times higher in patients of pSS. Logistic regression analysis showed that dry cough (OR 59.05), clubbing (OR 6.26), elevated lactate dehydrogenase (OR 21.38) and positive anti-Ro (OR 7.86) were relevant factors of pSS-ILD. ILD is the common pulmonary involvement of pSS and the prevalence of pSS-ILD is 39.1%. The single pattern of NSIP and UIP in HRCT are the commonest, and about 40% of the pSS-ILD patients possess multiple patterns in HRCT. The classification of idiopathic pulmonary fibrosis cannot completely include the pulmonary imaging features of pSS-ILD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Palm O, Garen T, Berge Enger T, Jensen JL, Lund MB, Aalokken TM, Gran JT (2013) Clinical pulmonary involvement in primary Sjogren’s syndrome: prevalence, quality of life and mortality-a retrospective study based on registry data[J]. Rheumatology 52(1):173–179

    Article  Google Scholar 

  2. Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, Kim DS, Handa T, Izumi T, Mishima M (2005) Pulmonary manifestations of primary Sjogren’s syndrome: a clinical, radiologic, and pathologic study[J]. Am J Resp Crit Care 171(6):632–638

    Article  Google Scholar 

  3. Sebastian A, Misterska-Skora M, Silicki J, Sebastian M, Wiland P (2017) Chest HRCT findings in patients with primary Sjogren’s syndrome[J]. Adv Clin Exp Med 26(7):1101–1106

    Article  Google Scholar 

  4. Yazisiz V, Arslan G, Ozbudak IH, Turker S, Erbasan F, Avci AB, Ozbudak O, Terzioglu E (2010) Lung involvement in patients with primary Sjogren’s syndrome: what are the predictors? [J]. Rheumatol Int 30(10):1317–1324

    Article  Google Scholar 

  5. Shi JH, Liu HR, Xu WB, Feng RE, Zhang ZH, Tian XL, Zhu YJ (2009) Pulmonary manifestations of Sjogren’s syndrome[J]. Respiration 78(4):377–386

    Article  Google Scholar 

  6. Li X, Xu B, Ma Y, Li X, Cheng Q, Wang X, Wang G, Qian L, Wei L (2015) Clinical and laboratory profiles of primary Sjogren’s syndrome in a Chinese population: a retrospective analysis of 315 patients[J]. Int J Rheum Dis 18(4):439–446

    Article  CAS  Google Scholar 

  7. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D (2013) An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias[J]. Am J Resp Crit Care 188(6):733–748

    Article  Google Scholar 

  8. Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group[J]. Ann Rheum Dis 61(6):554–558

    Article  CAS  Google Scholar 

  9. Shiboski CH, Shiboski SC, Seror R et al (2016) American College of Rheumatology/European League Against Rheumatism Classification Criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts[J]. Arthritis Rheumatol, 2017 69(1):35–45

    Google Scholar 

  10. Guo X, Bao N, Lei Z et al (2011) Quantitative comparative analysis of high-resolution CT features of idiopathic interstitial pneumonia[J]. Chin J Med 1:11–15

    Google Scholar 

  11. Nannini C, Jebakumar AJ, Crowson CS et al (2013) Primary Sjogren’s syndrome 1976-2005 and associated interstitial lung disease: a population-based study of incidence and mortality[J]. BMJ Open 3(11):003569–003576

    Article  Google Scholar 

  12. Deheinzelin D, Capelozzi VL, Kairalla RA, Barbas Filho JV, Saldiva PH, de Carvalho CR. Interstitial lung disease in primary Sjogren’s syndrome. Clinical-pathological evaluation and response to treatment[J]. Am J Resp Crit Care, 1996, 154(3 Pt 1):794–799

    Article  CAS  Google Scholar 

  13. Garcia-Carrasco M, Ramos-Casals M, Rosas J et al (2002) Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients[J]. Medicine 81(4):270–280

    Article  Google Scholar 

  14. Stojan G, Baer AN, Danoff SK (2013) Pulmonary manifestations of Sjogren’s syndrome[J]. Curr Allergy Asthma Rep 13(4):354–360

    Article  Google Scholar 

  15. Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH (2006) Interstitial lung disease in primary Sjogren syndrome[J]. Chest 130(5):1489–1495

    Article  Google Scholar 

  16. Pertovaara M, Pukkala E, Laippala P et al (2001) A longitudinal cohort study of Finnish patients with primary Sjogren’s syndrome: clinical, immunological, and epidemiological aspects[J]. Ann Rheum Dis 60(5):467–472

    Article  CAS  Google Scholar 

  17. Baldini C, Pepe P, Quartuccio L, Priori R, Bartoloni E, Alunno A, Gattamelata A, Maset M, Modesti M, Tavoni A, de Vita S, Gerli R, Valesini G, Bombardieri S (2014) Primary Sjogren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients[J]. Rheumatology 53(5):839–844

    Article  Google Scholar 

  18. Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S (2016) Pulmonary manifestations of Sjogren’s syndrome[J]. Eur Respir Rev 25(140):110–123

    Article  Google Scholar 

  19. Roca F, Dominique S, Schmidt J, Smail A, Duhaut P, Lévesque H, Marie I (2017) Interstitial lung disease in primary Sjogren’s syndrome[J]. Autoimmun Rev 16(1):48–54

    Article  CAS  Google Scholar 

  20. Manfredi A, Sebastiani M, Cerri S, Cassone G, Bellini P, Casa GD, Luppi F, Ferri C (2017) Prevalence and characterization of non-sicca onset primary Sjogren syndrome with interstitial lung involvement[J]. Clin Rheumatol 36(6):1261–1268

    Article  Google Scholar 

  21. Matsuyama N, Ashizawa K, Okimoto T, Kadota J, Amano H, Hayashi K (2003) Pulmonary lesions associated with Sjogren’s syndrome: radiographic and CT findings[J]. Br J Radiol 76(912):880–884

    Article  CAS  Google Scholar 

  22. Lin DF, Yan SM, Zhao Y et al (2010) Clinical and prognostic characteristics of 573 cases of primary Sjogren’s syndrome[J]. Chin Med J 123(22):3252–3257

    PubMed  Google Scholar 

  23. Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, del Pino-Montes J, Calvo-Alen J, Jiménez-Alonso J, Micó ML, Beltrán J, Belenguer R, Pallarés L (2008) Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients[J]. Medicine 87(4):210–219

    Article  CAS  Google Scholar 

  24. Huber AM, Mamyrova G, Lachenbruch PA, Lee JA, Katz JD, Targoff IN, Miller FW, Rider LG, for the Childhood Myositis Heterogeneity Collaborative Study Group (2014) Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies[J]. Arthritis Care Res 66(5):732–740

    Article  Google Scholar 

  25. Zheng Y (2015) A new understanding of interstitial lung disease in connective tissue[J]. Chin J Rheumatol 9:577–579

    Google Scholar 

  26. Mekinian A, Nicaise-Roland P, Chollet-Martin S, Fain O, Crestani B (2013) Anti-SSA Ro52/Ro60 antibody testing by immunodot could help the diagnosis of Sjogren’s syndrome in the absence of anti-SSA/SSB antibodies by ELISA[J]. Rheumatology (Oxford) 52(12):2223–2228

    Article  CAS  Google Scholar 

  27. Sambataro D, Sambataro G, Dal Bosco Y, Polosa R (2017) Present and future of biologic drugs in primary Sjogren’s syndrome[J]. Expert Opin Biol Th 17(1):63–75

    Article  CAS  Google Scholar 

  28. Espinosa A, Dardalhon V, Brauner S et al (2009) Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway[J]. Medicine 206(8):1661–1671

    CAS  Google Scholar 

  29. Kusume K (1991) Lung injury in idiopathic pulmonary fibrosis and measurement of immunoreactive neutrophil elastase and alpha 1-protease inhibitor in blood[J]. Nihon Kyobu Shikkan Gakkai Zasshi 29(10):1254–1260

    CAS  PubMed  Google Scholar 

  30. Zhang Y, Li H, Wu N, Dong X, Zheng Y (2017) Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease[J]. Clin Rheumatol 36(4):817–823

    Article  Google Scholar 

  31. Yazisiz V, Ozbudak IH, Nizam I, Erbasan F, Avci AB, Ozbudak O, Terzioglu E (2010) A case of primary Sjogren’s syndrome with pulmonary-limited Wegener’s granulomatosis[J]. Rheumatol Int 30(9):1235–1238

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Dong Xin and Junfei Zhou contributed equally to this work.

Authors and Affiliations

  1. Department of Rheumatology and Immunology, Beijing Chaoyang Hospital, Capital Medical University, No. 8 Gong-Ti South Road, Chaoyang District, Beijing, 100020, People’s Republic of China

    Xin Dong, Junfei Zhou, Yifan Li, Yuetong Xu, Qiang Fu & Yi Zheng

  2. Department of Radiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China

    Xiaojuan Guo

  3. Department of Respiratory Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China

    Yong Lu

Authors
  1. Xin Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Junfei Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaojuan Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yifan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuetong Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qiang Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yong Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yi Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yi Zheng.

Ethics declarations

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dong, X., Zhou, J., Guo, X. et al. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren’s syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol 37, 2981–2988 (2018). https://doi.org/10.1007/s10067-018-4289-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-018-4289-6

Keywords

Search

Navigation